CBD gummies in Australia sit in a category where regulation and supply have not aligned. The direct answer: no CBD gummy currently holds ARTG listing for over-the-counter pharmacy sale, which means there is no TGA-registered gummy a pharmacist can hand you without a prescription. FraLa CBD is a Byron Bay, NSW CBD oil label — we do not stock gummies, and this article explains the regulatory gap, how the two formats differ in how cannabidiol enters the body, and what we carry instead.
What are CBD gummies?
A CBD gummy is hemp-derived cannabidiol embedded in a confection base — sweetener, a gelling agent (gelatine or a plant-based substitute), flavouring and colouring. The cannabinoid content is stated in milligrams per piece; a typical international gummy runs 10–25 mg of CBD per piece.
The spectrum type applies to gummies exactly as it does to oils. A full-spectrum gummy retains the whole hemp cannabinoid profile, including trace THC at legal levels. A broad-spectrum gummy has THC removed (0% THC). An isolate gummy contains only purified cannabidiol. The active molecule in all three cases is the same cannabidiol found in a bottle of CBD oil.
What sets a gummy apart compositionally is the confection stack — sugar or sweetener alternative, gelling agent, food-grade flavour and colour. A CBD oil has a far shorter ingredient list: hemp extract and a neutral carrier oil (MCT derived from coconut in the FraLa CBD range). Two ingredients versus a full confection deck. For anyone who reads labels carefully, the shorter list is easier to verify.
The regulatory picture — what the TGA says about CBD gummies in Australia
Understanding the Australian market starts with the Therapeutic Goods Administration (TGA), the government body that regulates cannabidiol products under the Poisons Standard.
In 2021, the TGA down-scheduled low-dose CBD — up to 150 mg per day — from Schedule 4 (prescription-only) to Schedule 3 (pharmacist-only medicine), opening a pathway for CBD products to be sold in pharmacies without a GP prescription. The catch is that Schedule 3 access requires ARTG listing: a product must be assessed and entered on the Australian Register of Therapeutic Goods before a pharmacist can dispense it. As of 2026, no CBD gummy product holds ARTG listing for over-the-counter sale in Australia. The Schedule 3 door is open in principle; no gummy manufacturer has yet walked a registered product through it.
What circulates online is a different matter. Some products marketed as CBD gummies to Australian shoppers are categorised as hemp food supplements — assessed under food standards, not the TGA's therapeutic framework — or are imported under personal use provisions. Those products have not gone through the same assessment process as an ARTG-listed therapeutic good, and different labelling rules apply to them.
For the full legal framework — Schedule 3 versus Schedule 4, the prescription pathway for higher-dose products, and where online CBD oil fits — the CBD oil laws in Australia guide covers the specifics.
CBD gummies vs CBD oil — how the absorption pathways differ
The cannabidiol molecule is chemically identical in a gummy and in an oil. What differs is how it reaches the bloodstream.
Gummies: the oral-digestive route. When you eat a CBD gummy, it passes through the stomach, small intestine, and then the liver before reaching the bloodstream. The liver is where first-pass metabolism occurs — enzymes process a proportion of the cannabidiol before it enters systemic circulation. Published figures on oral CBD bioavailability put the absorbed amount at roughly 6–15% of the labelled dose. Onset is correspondingly slow: 45 minutes to two hours is a typical range.
CBD oil: the sublingual route. CBD oil held under the tongue for around 60 seconds uses the mucous membrane there as an absorption pathway. Blood vessels in that membrane allow a portion of the cannabidiol to pass into the bloodstream before the remainder is swallowed and follows the digestive route. Sublingual CBD oil has an estimated bioavailability of 20–35% in published literature — roughly two to four times higher than the oral route — with onset typically around 10–15 minutes.
In practical terms: a 10 mg sublingual CBD oil serving will often deliver more absorbed cannabidiol than a 25–30 mg gummy, even though the gummy has more milligrams on the label. This is a format and absorption fact, not a therapeutic recommendation — FraLa CBD does not give dosing or medical advice, and a higher bioavailability figure does not constitute a claim about suitability for any condition. For a practical walkthrough of the dropper and label figures, the guide to taking CBD oil covers each step.
From our CBD oil range
CBD Oil 3000mg – Broad Spectrum
Broad-spectrum CBD — all the supporting cannabinoids and terpenes from the hemp plant, with THC removed. 3000mg in a 50ml MCT bottle (60mg per ml).
CBN Oil 1000mg – Cannabinol
Cannabinol — the cannabinoid that forms as raw hemp ages. 1000mg of CBN isolate in 50ml of MCT oil (20mg per ml). A common choice for evening routines among people already familiar with CBD.
Pet CBD Oil 2000mg – Full Spectrum
Pet-formulated CBD oil — same hemp source as our human range, neutral MCT carrier, no human-targeted flavours or sweeteners. 2000mg in 50ml of MCT oil (40mg per ml). Best introduced under guidance from your vet.
What FraLa CBD stocks — and why we don't carry gummies
FraLa CBD sells CBD oil, not gummies. We are not planning to add gummies: no TGA-registered gummy exists for OTC sale in Australia, which means any gummy we stocked would sit in an unregistered supplement or import category — a murkier regulatory lane than we want to operate in.
Our range covers five product families, all sourced from EU Labs and third-party batch-tested, with a Certificate of Analysis available on request:
- Full-spectrum CBD oil — whole-plant hemp extract, trace THC under 0.3%, MCT carrier. From $89.95 / 1000mg / 50ml.
- Broad-spectrum CBD oil — whole-plant hemp extract, THC removed to 0% THC, MCT carrier.
- CBG oil (cannabigerol) — hemp-derived, MCT carrier.
- CBN oil (cannabinol) — THC-free isolate, MCT carrier.
- Pet CBD oil — pet-formulated hemp-derived CBD, MCT carrier.
Browse all five families on the FraLa CBD shop. For the composition difference between full-spectrum and broad-spectrum — cannabinoid profiles, the THC figures, the processing step that distinguishes them, and what the batch COA confirms for each — the full-spectrum vs broad-spectrum guide goes through it in detail.
If the gummy format is specifically what you need rather than the cannabidiol in a different vehicle, we are not the right shop. We would rather say that plainly.
What to check before buying any CBD product in Australia
Whether you are looking at a gummy or an oil — from us or from anyone else — these are the label and documentation points that actually matter.
ARTG status. A product marketed as a therapeutic good must hold ARTG listing to be legally sold in Australia as such. You can search the register directly on the TGA website; a product not listed is not a registered Australian therapeutic good, regardless of what the label says.
Spectrum type. Full-spectrum retains trace THC (under 0.3%, confirmed by the batch COA). Broad-spectrum has THC removed (0% THC). Isolate is a single purified cannabinoid. Know which one you are buying.
Total milligrams. The strength figure on the label — 1000mg, 3000mg — refers to the total cannabidiol in the whole bottle or package, not per serving. Divide by the number of servings to get per-serving milligrams.
THC statement. Declared on any compliant label and confirmed by the batch COA. Know whether trace THC is present or the product is confirmed THC-free before you buy.
Batch Certificate of Analysis. A COA from an independent, accredited laboratory matched to the lot number on your specific product is the baseline standard for any CBD product. A general company COA does not cover your batch. At FraLa CBD, email enquiries@franklauda.com with the lot number from your bottle and we send the matching batch COA.
Ingredients. An oil is hemp extract and carrier oil — a two-ingredient list. A gummy carries the full confection stack. If dietary requirements matter, read the full ingredients list, not just the cannabinoid panel.
The full regulatory context is in the Australian CBD oil laws guide. Delivery to Sydney and across the country is covered on the CBD oil Sydney page.
Frequently asked questions
Are CBD gummies legal to buy in Australia? Cannabidiol is legal in Australia under defined frameworks. Low-dose CBD is Schedule 3 — but that requires ARTG listing, and no CBD gummy currently holds that listing for OTC sale. Products marketed online vary in how they are categorised. The TGA is the authoritative source.
Why doesn't FraLa CBD sell CBD gummies? No TGA-registered CBD gummy exists for OTC sale. Stocking one would mean operating in a less clearly defined regulatory lane. We stock CBD oil — third-party batch-tested, COA on request.
What's the difference between CBD gummies and CBD oil? The active cannabinoid (cannabidiol) is the same molecule in both. The difference is the surrounding ingredients (confection base vs carrier oil) and the absorption pathway: gummies go through the full digestive system including liver first-pass; CBD oil held sublingually partially bypasses that, with higher bioavailability and faster onset.
Does FraLa CBD ship CBD oil to Sydney and other cities? Yes. From Byron Bay, NSW, we ship to Sydney, Melbourne, Brisbane, Perth, Adelaide and Canberra. City details are on the CBD oil Sydney page. The full range is on the shop page.
What is TGA Schedule 3 and does it apply to gummies? Schedule 3 is the pharmacist-only classification that allows low-dose CBD to be sold without a GP prescription. The TGA moved low-dose CBD (up to 150 mg per day) to Schedule 3 in 2021 — but Schedule 3 only applies to products with ARTG listing. As of 2026, no CBD gummy has achieved that listing for OTC sale. The CBD oil laws guide covers the detail.
